Annual Current Ratio:
2.37-0.24(-9.20%)Summary
- As of today, RARE annual current ratio is 2.37, with the most recent change of -0.24 (-9.20%) on December 31, 2024.
- During the last 3 years, RARE annual current ratio has fallen by -2.35 (-49.79%).
- RARE annual current ratio is now -91.26% below its all-time high of 27.12, reached on December 31, 2012.
Performance
RARE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Current Ratio:
2.45+0.05(+2.08%)Summary
- As of today, RARE quarterly current ratio is 2.45, with the most recent change of +0.05 (+2.08%) on June 30, 2025.
- Over the past year, RARE quarterly current ratio has dropped by -1.09 (-30.79%).
- RARE quarterly current ratio is now -90.97% below its all-time high of 27.12, reached on December 31, 2012.
Performance
RARE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
RARE Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -9.2% | -30.8% |
| 3Y3 Years | -49.8% | -20.4% |
| 5Y5 Years | -71.2% | -40.5% |
RARE Current Ratio Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -49.8% | at low | -44.9% | +3.8% |
| 5Y | 5-Year | -71.2% | at low | -70.9% | +3.8% |
| All-Time | All-Time | -91.3% | at low | -91.0% | +544.7% |
RARE Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | 2.45(+2.1%) |
| Mar 2025 | - | 2.40(+1.3%) |
| Dec 2024 | 2.37(-9.2%) | 2.37(-15.7%) |
| Sep 2024 | - | 2.81(-20.6%) |
| Jun 2024 | - | 3.54(+45.7%) |
| Mar 2024 | - | 2.43(-6.9%) |
| Dec 2023 | 2.61(-22.8%) | 2.61(+10.6%) |
| Sep 2023 | - | 2.36(-17.8%) |
| Jun 2023 | - | 2.87(-18.2%) |
| Mar 2023 | - | 3.51(+3.8%) |
| Dec 2022 | 3.38(-28.4%) | 3.38(-24.0%) |
| Sep 2022 | - | 4.45(+44.5%) |
| Jun 2022 | - | 3.08(-27.2%) |
| Mar 2022 | - | 4.23(-10.4%) |
| Dec 2021 | 4.72(-30.9%) | 4.72(-24.2%) |
| Sep 2021 | - | 6.23(-16.6%) |
| Jun 2021 | - | 7.47(-11.4%) |
| Mar 2021 | - | 8.43(+23.4%) |
| Dec 2020 | 6.83(-17.1%) | 6.83(+57.7%) |
| Sep 2020 | - | 4.33(+5.1%) |
| Jun 2020 | - | 4.12(-9.3%) |
| Mar 2020 | - | 4.54(-44.9%) |
| Dec 2019 | 8.24 | 8.24(+21.4%) |
| Sep 2019 | - | 6.79(-27.2%) |
| Jun 2019 | - | 9.33(-20.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | 11.77(+68.4%) |
| Dec 2018 | 6.99(+83.9%) | 6.99(-17.9%) |
| Sep 2018 | - | 8.51(-7.1%) |
| Jun 2018 | - | 9.16(-9.3%) |
| Mar 2018 | - | 10.10(+165.8%) |
| Dec 2017 | 3.80(-43.0%) | 3.80(-37.5%) |
| Sep 2017 | - | 6.08(-9.3%) |
| Jun 2017 | - | 6.70(-22.0%) |
| Mar 2017 | - | 8.59(+28.8%) |
| Dec 2016 | 6.67(-58.6%) | 6.67(-19.2%) |
| Sep 2016 | - | 8.26(-35.7%) |
| Jun 2016 | - | 12.85(-10.8%) |
| Mar 2016 | - | 14.40(-10.7%) |
| Dec 2015 | 16.13(+4.4%) | 16.13(-13.4%) |
| Sep 2015 | - | 18.63(+27.5%) |
| Jun 2015 | - | 14.61(-40.6%) |
| Mar 2015 | - | 24.61(+59.3%) |
| Dec 2014 | 15.45(+65.6%) | 15.45(-17.2%) |
| Sep 2014 | - | 18.67(+5.7%) |
| Jun 2014 | - | 17.66(-29.1%) |
| Mar 2014 | - | 24.91(+167.0%) |
| Dec 2013 | 9.33(-65.6%) | 9.33(+2355.3%) |
| Sep 2013 | - | 0.38(-97.9%) |
| Jun 2013 | - | 17.82(-34.3%) |
| Dec 2012 | 27.12(+147.4%) | 27.12 |
| Dec 2011 | 10.96 | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual current ratio?
- What is the all-time high annual current ratio for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual current ratio year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly current ratio?
- What is the all-time high quarterly current ratio for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly current ratio year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual current ratio?
The current annual current ratio of RARE is 2.37
What is the all-time high annual current ratio for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual current ratio is 27.12
What is Ultragenyx Pharmaceutical Inc. annual current ratio year-on-year change?
Over the past year, RARE annual current ratio has changed by -0.24 (-9.20%)
What is Ultragenyx Pharmaceutical Inc. quarterly current ratio?
The current quarterly current ratio of RARE is 2.45
What is the all-time high quarterly current ratio for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly current ratio is 27.12
What is Ultragenyx Pharmaceutical Inc. quarterly current ratio year-on-year change?
Over the past year, RARE quarterly current ratio has changed by -1.09 (-30.79%)